PTPRZ1 and Parkinson disease: In the context of other brain disorders, Egr1 has been shown to regulate the expression of the glial scar component phosphacan in astrocytes after experimental stroke [103], and to push neurodegeneration and neuroinflammation in a model for Parkinson’s disease [104].